Chinese Association for Biomaterials 

华人生物材料协会

CAB Member News

<< First  < Prev   1   2   Next >  Last >> 
  • 3 May 2022 6:52 PM | Malcolm Xing (Administrator)

    The unprecedent COVID-19 pandemic had interrupted all in-person conferences and meetings. Now CAB Reception and Award Ceremony for 2022 is finally back with an exciting schedule to bring you the best gathering and networking you expect from CAB. This year’s reception took place in Baltimore, MD on April 28, 2022, as a special even at the SFB annual meeting.



    More than 50 attendees from all over the world gathered together to celebrate the CAB Awards for 2022, among them, two internationally-renowned professors, Dr. Guillermo Ameer and Dr. Xuesi Chen, were the awardees of the Global Biomaterials Leadership Award.


    Moreover, a dinner at the local restaurant “Red Pepper” attended by all witnessed how close our CAB family could be. It is really exciting that our CAB family is growing every day, and we appreciate your continuous support and patriotism, so please join us in the next events sponsored by CAB.


  • 3 May 2022 10:49 AM | Malcolm Xing (Administrator)

    We are pleased to announce the winners of the CAB Awards in 2022! The CAB Global Biomaterials Leadership Award is awarded to Prof. Guillermo Ameer and Prof. Xuesi Chen to recognize their distinguished leadership in advancing the basic and translational research in biomaterials. The CAB Mid-Career, Young Investigator, and Trainee Awards go to Prof. Guohao Dai, Prof. YiZhou Dong, Prof. Xin Zhao, Prof. Guojun Chen, Prof. Yu Huang, Dr. Yang Liu, and Dr. Yuyuan Wang, respectively, for their excellent achievements in biomaterials research. Please join us to congratulate all the CAB award winners!




    Global Biomaterials Leadership Award

    • ·       Dr Guillermo Ameer (Northwestern University) 
    • ·       Dr Xuesi Chen (Chinese Academy of Sciences)


     

    Mid-Career Award

    • ·       Dr Guohao Dai (Northeastern University)
    • ·       

      • Dr Yizhou Dong (The Ohio State University)

    • Yizhou Dong
    •  Dr Xin Zhao (The Polytechnique University of Hong Kong)
    • Dr Xin Zhao

    Young Investigator Award

    • ·       Dr Guojun Chen (McGill University)
    • IMG_8354.PNG
    • ·       Dr Yu Huang (Utah State University)

    Trainee Award

    • ·       Dr Yang Liu (University of Connecticut, Storrs Campus)

    • ·       Dr Yuyuan Wang (University of Wisconsin-Madison)
    •  


  • 16 Jan 2022 7:50 PM | Anonymous

    Contact Info: Yunzhi Peter Yang, ypyang@stanford.edu

    Description:

    One postdoctoral position in bone biology and/or stem cell biology is available immediately in the lab of Professor Yunzhi Peter Yang, Departments of Orthopedic Surgery at Stanford University at https://med.stanford.edu/yanglab.html. The candidates with strong biology and surgery experimental experience and interest in the areas of tissue regeneration is sought to participate in the NIH and DOD funded projects. The Lab particularly emphasizes development of multidisciplinary and novel approaches to address relevant biomedical questions in musculoskeletal tissue applications. Highly motivated candidates with experimental background, strong academic and publication record, and the ability to work independently and collaboratively with a strong commitment are invited to apply. Interested candidates should send a cover letter, their CV, and the names and contact information of three references electronically to the email address given below, ypyang@stanford.edu. The positions are open immediately.

    Qualifications:

    The postdoctoral fellow will participate in the projects involving stem cells and requires a strong background in stem cell biology, bone biology, genetic editing and surgical skills in orthopedic trauma and tendon injury in vivo models. The applicants who have abundant experience with cell culture, RNA extraction, qRT-PCR, bioinformatic analysis, tissue analysis techniques, such as paraffin embedding, tissue sectioning, immunohistological staining, histomorphometry, micro-CT, and mechanical tests, and orthopaedic surgery for rodents are highly encouraged for application.

  • 7 Jul 2020 9:00 AM | Anonymous


    The first Impact Factor of Bioactive Materials was released and the journal achieved an impact factor of 8.724. It ranks 2nd out of 38 journals in Materials Science, Biomaterials category and 5th out of 87 journals in Engineering, Biomedical category. Bioactive Materials is an international, peer-reviewed research publication covering all aspects of bioactive materials (http://www.keaipublishing.com/en/journals/bioactive-materials/). Congratulations to all editorial board members!

  • 18 May 2020 9:00 AM | Anonymous

    Dr. Hu Yang will begin his new role as the chair of the chemical and biochemical engineering department at Missouri S&T on 8/1/2020. Yang joins Missouri S&T from Virginia Commonwealth University (VCU) where he is the Qimonda Endowed Chair in chemical and life science engineering, biomedical engineering, and pharmaceutics. Congratulations! 

    Source:  Missouri S&T

  • 7 May 2020 9:00 AM | Anonymous

    We are pleased to announce the winners of the CAB Awards in 2020! The CAB Global Biomaterials Leadership Award is awarded to Prof. Kam W Leong and Prof. David L. Kaplan to recognize their distinguished leadership in advancing the basic and translational research in biomaterials. The CAB Mid-Career, Young Investigator, and Trainee Awards go to Prof. Jingwei Xie, Prof. Yi Hong, Prof. Y. Shrike Zhang, Prof. Eun Ji Chung, Dr. Xuehui Zhang, Dr. Peng Shi, and Dr. Guomin Wang, respectively, for their excellent achievements in biomaterials research. Please join us to congratulate all the CAB award winners!

    CAB Global Biomaterials Leadership Award

    Prof. Kam W Leong (Columbia University)

    Prof. David L. Kaplan (Tufts University)

    CAB Mid-Career Award

    Prof. Jingwei Xie (University of Nebraska Medical Center)

    Prof. Yi Hong (University of Texas at Arlington)

    CAB Young Investigator Award

    Prof. Y. Shrike Zhang (Harvard Medical School)

    Prof. Eun Ji Chung (University of Southern California)

    CAB Trainee Award

    Dr. Xuehui Zhang (Peking University School and Hospital of Stomatology)

    Dr. Peng Shi (The Pennsylvania State University)

    Dr. Guomin Wang (City University of Hong Kong)


    Biography of awardees


  • 14 Feb 2020 5:00 PM | Anonymous

    Sepsis, a severe condition caused by infections, affects millions of people worldwide every year and remains the leading cause of death in hospitals. In addition, multidrug-resistant (MDR) bacteria have become an additional challenge in the treatment of sepsis and thus, effective therapeutics are urgently needed. A recent paper from Dr. Yizhou Dong and his collaborators at The Ohio State University reported a novel approach for overcoming MDR bacteria-induced sepsis that combines vitamin derived lipid nanoparticles with adoptive macrophage therapy. In this study, the adoptive transfer of macrophages containing antimicrobial peptides in the lysosomes (MACs) reduced bacterial burden and improve survival in the sepsis mouse models. This work was published in Nature Nanotechnology (https://www.nature.com/articles/s41565-019-0600-1).


  • 14 Feb 2020 8:00 AM | Anonymous

    Cell replacement therapy such as intrahepatic transplantation of donor islets is relatively successful for type 1 diabetes in some patients. However, there are a number of limitations including immediate blood-mediated inflammatory response, potential risks of thrombosis and localized steatosis, and inability to retrieve or replace failed cells. Subcutaneous site is less invasive and easier-to-access but lacks sufficient vasculature to support the islet function. Dr. Minglin Ma and his collaborators reported a pre-vascularized islet construct that functioned in the subcutaneous site and corrected diabetes in mice for 3 months. (https://doi.org/10.1038/s41467-019-12373-5)


  • 12 Feb 2020 8:00 AM | Anonymous

    Glucose-responsive insulin delivery systems that mimic pancreatic endocrine function could enhance health and improve quality of life for people with type 1 and type 2 diabetes with reduced β-cell function. Recently, a research team led by Zhen Gu, a professor of bioengineering at the UCLA Samueli School of Engineering and a member of CAB, developed a smart insulin-delivery patch that could one day monitor and manage glucose levels in people with diabetes and deliver necessary insulin dosage. In the experiments, one quarter-sized patch successfully controlled glucose levels in pigs (> 25 kg) with type I diabetes for about 20 hours. A study describing the research in which the patch was published in Nature Biomedical Engineering (https://doi.org/10.1038/s41551-019-0508-y).

  • 20 Apr 2019 1:55 PM | Anonymous

    In collaboration with Society for Biomaterials (SFB), CAB successfully organized a Biomaterials Science Excellence and Technology Translation Workshop at the SFB Annual Meeting in Seattle, WA on April 3, 2019. The workshop included invited presentations/lectures from global biomaterial leaders in biomaterials science and a panel discussion to discuss biomaterial innovation, international collaboration, venture investment, company startups, intellectual property, and other key elements en route to successful biomaterial technology translation. CAB also took this opportunity to present awards to a few outstanding scientists in three categories: CAB Global Biomaterials Leadership Award, CAB Mid-Career Investigator Award, and CAB Young Investigator Award.

    CAB Global Biomaterials Leadership Awards

                              

             Prof. Cato Laurencin (Middle)                     Prof. Changsheng Liu (Middle)

    Cato Laurencin, MD, PhD

    Cato T. Laurencin, M.D., Ph.D. is a University Professor at the University of Connecticut (the 8th to be designated in the institution’s over 140 year history). He is the Albert and Wilda Van Dusen Distinguished Endowed Professor of Orthopaedic Surgery. He is Professor of Chemical, and Biomolecular Engineering, Professor of Materials Science and Engineering, and Professor of Biomedical Engineering at UCONN. Dr. Laurencin is the Founder and Director of the Raymond and Beverly Sackler Center for Biomedical, Biological, Physical and Engineering Sciences at the University of Connecticut and C.E.O. of The Connecticut Convergence Institute for Translation in Regenerative Engineering at UCONN. Dr. Laurencin is an elected member of the National Academy of Medicine and an elected member of the National Academy of Engineering. Internationally, he is an elected Fellow of the African Academy of Sciences, an elected Fellow (Foreign) of the India National Academy of Sciences, an elected Fellow (Foreign) of the Indian National Academy of Engineering and is a Fellow of The World Academy of Sciences. Dr. Laurencin is an Academician and Member (Foreign) of the Chinese Academy of Engineering. This award recognizes his global leadership in biomaterials innovation and technology translation.

    Changsheng Liu, PhD

    Changsheng Liu, PhD. is the Cheung Kong Scholar Professor of East China University of Science and Technology (ECUST), Academician of Chinese Academy of Sciences. Dr. Liu is currently the vice President of ECUST,director of Engineering Research Center for Biomaterial Materials of Ministry of Education,and director of Key Laboratory for Ultrafine Materials of Ministry of Education. His major research areas include biomaterials and tissue regeneration, fabrication of inductive growth factors, and designing of bioactive skeletal substitutes for bone repair. He developed a few novel biomaterials and received CFDA approvals. He was elected to the fellow of international Biomaterials Science and Engineering (2012) and American Institute for Medical and Biological Engineering (AIMBE) Fellow (2018). He was also a recipient of Ho Leung Ho Lee Foundation-Prize for Scientific and Technological Innovation Award (2007), the National Award for Natural Science (The Second Place) in 2014, the National Award for Science and Technology Progress (The Second Place) in 2003. This award recognizes his global leadership in biomaterials innovation and technology translation.

    CAB Mid-Career Investigator Awards

                                       

    Prof. Liming Bian (Middle)           Prof. Qiaobing Xu (Middle)          Prof. Donghui Zhu (Middle)

    Liming Bian, PhD

    Liming Bian, PhD is currently an Associate Professor in the Department of Biomedical Engineering at the Chinese University of Hong Kong. He was recognized for his innovative work on biofunctionalizing biomaterials for stem cell-based regenerative therapies. The findings from these studies provide the critical insights to the design of polymeric biomaterials with molecular dynamics for enhanced biomaterial functions. Dr. Bian’s research work has been published in the leading journals including PNAS, JACS, Nano Letters, Biomaterials, Advanced Materials, Advanced Functional Materials, Advanced Science, ACS Nano, ACS Central Science, Macromolecules, Small, and Chemistry of Materials. He was a receipent of BMES CMBE Rising Star Award, CHUK Young Researcher Award, and Asian Biomaterials Congress Young Investigator Award.

    Qiaobing Xu, PhD

    Qiaobing Xu, PhD is an Associate Professor of Biomedical Engineering at Tufts University. He was recognized for his contribution on developing synthetic biodegradable lipid like materials for intracellular protein delivery for therapeutics including rare diseases and genome editing. His work has been published in leading journals such as Nature, Nature BME, JCI, PNAS, JACS, Angew Chem, and highlighted by Science and news media such as Genomeweb and C&E News. Dr. Xu has received several notable awards, including Pew Scholar for Biomedical Sciences from Pew Charitable Trusts, NSF CAREER award and the Rising Star Award from BMES/CMBE program.

    Donghui Zhu, PhD

    Donghui Zhu, PhD is an Associate Professor of Biomedical Engineering at University of North Texas. He was recognized for his contribution to biodegradable metallic biomaterials for regenerative and translational medicine. Dr. Zhu have published over 50 peer-reviewed papers in prestigious journals such as Blood, Nature Neuroscience, Advanced Science, and Biomaterials. He was a recipient of Outstanding Junior Faculty Research Award from College of Engineering of North Carolina AT State University. He has recently received two NIH R01 grants.

    CAB Young Investigator Awards

                        

                Prof. Bin Duan (Middle)                  Prof. Michael Mitchell (Middle)     

    Bin Duan, PhD

    Bin Duan, PhD is an Assistant Professor at University of Nebraska Medical Center. He was recognized for his contribution on 3D bioprinting of living tissues to study stem cell functions. He has published more than 50 peer-reviewed papers, 8 book chapters, and 4 patents. Dr. Duan was a recipient of American Heart Association (AHA) Postdoctoral Fellowship, AHA Scientist Development Grant Award, Gilmore Distinguished New Investigator Award at UNMC, and Orthopedic Biomaterials SIG Outstanding Abstract Award at 2019 SFB Annual Conference (2019). His research has been funded by AHA SDG, and NIH (R01 and R21 as PI).

    Michael Mitchell, PhD

    Michael Michelle, PhD is a Skirkanich Assistant Professor of Innovation in the Department of Bioengineering at the University of Pennsylvania. He was recognized for his contribution on developing novel drug and gene delivery technologies for regenerative medicine and immunotherapy. He has received numerous award at his early career stage. To name a few, he was a recipient of NIH New Innovator Award, BMES Rising Star Award in Cellular and Molecular Bioengineering, Selected Delegate of Academy of Achievement International Summit, Burroughs Wellcome Fund Career Award at the Scientific Interface (CASI), and Skirkanich Assistant Professor of Innovation Endowed Chair.

    Workshop Panelists

    Qing Liu, PhD, President and CEO

    Beijing Advanced Medical Technologies

    President and CEO of Beijing Advanced Medical Technologies (AMT)Director of Engineering Research Center for Biomaterials & Medical Device 3D Printing at Fudan Zhangjiang Institute, adjunct Professor at Tongji University, Shanghai, China. Dr. Liu received his Ph.D. degree in biomaterials from Twente University (the Netherlands) in 1997, He did his postdoctoral training at Rice University from 1997-1999. Dr. Liu has over 25 years of R&D experience in biomaterials and medical device. From 2002-2007, Dr. Liu served as Director of Biomaterials R&D at Celgene Corporation where he directed the stem cell and biomaterial combination product development programs. He co-founded 3D Biotek in 2007 and served as CEO/CSO. In 2011, he founded AMT to develop totally bioresorbable coronary and peripheral stents using proprietary 3D printing technologies.

    Lihua Zheng, JD, PhD, Partner

    Zheng & Karg LLP

    Dr. Lihua Zheng, is a founding partner and owner of Zheng & Karg LLP. Dr. Zheng advises on both corporate and intellectual property aspects of technology commercialization. He specializes in IP licensing, venture capital financing, patent portfolio management, corporate partnering, and joint ventures. Dr. Zheng is licensed in the State of New York and the United States District Court for the Eastern District of New York. He is also a registered patent attorney at the United States Patent and Trademark Office. Dr. Zheng’s practice encompasses a broad range of technical areas, including biomaterials, biotechnologies, pharmaceuticals, nutraceuticals, botanical medicines, medical devices, healthcare, medical devices, and consumer products. With deep understandings of both technical and legal nature, Dr. Zheng is particularly experienced in serving companies in the healthcare industry such as life sciences and pharmaceutical companies.

    James Malayter, Managing Partner, Senior VP

    Acuitive Technologies, Inc.

    Mr. Malayter provides extensive product development and marketing experience gained from his years working in executive management positions for big companies such as Pfizer, Howmedica and Zimmer. He has also played a pivotal role in guiding several start-up companies such as Osteonics, Implex Corp. and Pipeline Orthopedics to successful exits. His tenure in teaching Biology, Chemistry and Physics assisted his ability to communicate complex concepts into tangible medical devices that are designed to improve patient clinical outcomes. Through his direct interaction with surgeons and scientists he has helped to develop several technologies that have defined a new standard in their respective market segments (i.e. Trabecular Metal). Mr. Malayter is currently a Founding Partner in Acuitive Technologies, Inc.

    Cato T. Laurencin, MD, PhD, University Professor

    University of Connecticut

    Cato T. Laurencin, M.D., Ph.D. is a University Professor at the University of Connecticut (the 8th to be designated in the institution’s over 140-year history). He is the Albert and Wilda Van Dusen Distinguished Endowed Professor of Orthopaedic Surgery. He is Professor of Chemical, and Biomolecular Engineering, Professor of Materials Science and Engineering, and Professor of Biomedical Engineering at UCONN. Dr. Laurencin is the Founder and Director of the Raymond and Beverly Sackler Center for Biomedical, Biological, Physical and Engineering Sciences at the University of Connecticut and C.E.O. of The Connecticut Convergence Institute for Translation in Regenerative Engineering at UCONN. Dr. Laurencin is an elected member of the National Academy of Medicine and an elected member of the National Academy of Engineering. Internationally, he is an elected Fellow of the African Academy of Sciences, an elected Fellow (Foreign) of the India National Academy of Sciences, an elected Fellow (Foreign) of the Indian National Academy of Engineering and is a Fellow of The World Academy of Sciences. Dr. Laurencin is an Academician and Member (Foreign) of the Chinese Academy of Engineering.

    Changsheng Liu, PhD, VP

    East China University of Science and Technology (ECUST)

    Changsheng Liu, PhD. is the Cheung Kong Scholar Professor of East China University of Science and Technology (ECUST), Academician of Chinese Academy of Sciences. Dr. Liu is currently the vice President of ECUST,director of Engineering Research Center for Biomaterial Materials of Ministry of Education,and director of Key Laboratory for Ultrafine Materials of Ministry of Education. His major research areas include biomaterials and tissue regeneration, fabrication of inductive growth factors, and designing of bioactive skeletal substitutes for bone repair. He developed a few novel biomaterials and received CFDA approvals. He was elected to the fellow of international Biomaterials Science and Engineering (2012) and American Institute for Medical and Biological Engineering (AIMBE) Fellow (2018). He was also a recipient of Ho Leung Ho Lee Foundation-Prize for Scientific and Technological Innovation Award (2007), the National Award for Natural Science (The Second Place) in 2014, the National Award for Science and Technology Progress (The Second Place) in 2003.

    Hao Li, PhD

    Professor of University of Missouri, Columbia

    CEO of Nanova Inc.

    Hao Li is a professor in the Mechanical and Aerospace Engineering Department at the University of Missouri. Dr. Li’s research focuses on synthesis, characterization and application of novel nanomaterials and biomaterials. Dr. Li is an inventor of a biomimetic nanocomposite technology. Based on this technology, several dental and orthopedic products have been cleared by FDA and are currently available in the market. Li’s research has been funded by the NSF, NIH and other federal agencies and he is also a recipient of the NSF’s CAREER award. Dr. Li is also CEO and co-founder of Nanova Inc., a biotech start-up based in Columbia, MO. Nanova is currently working on three areas: medical devices, drug discovery and development, and environmental technologies. With both entrepreneurial and academic experience, Dr. Li is trying to build bridges between academia, industry, and financial firms in order to create unique values to the society. Dr. Li is trained as a materials scientist with bachelor and master degree from Xi’an Jiaotong University and Ph.D. degree from Stevens Institute of Technology and also obtained postdoctoral training from Brown University in nanotechnology.

    CAB thanks for the generous donations from the following workshop sponsors:

                                                                                                                           

    Nanova Inc.                       Beijing Advanced Medical Technologies

                                                                                       

                     Zheng&Karg LLP                                   Bioactive Materials                                        




<< First  < Prev   1   2   Next >  Last >> 

CAB is a non-profit organization.

Powered by Wild Apricot Membership Software